In general, the acquisition risk as well as the prevalence risk of mild cognitive impairment have been associated with the Apoε4 allele in aging cohorts (DeCarli et al. 2001; Lipnicki et al. 2017; Roberts et al. 2015). The gene discussed is APOE; the disease is Cognitive impairment.